AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 78 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $425,000 | -34.9% | 169,120 | +0.2% | 0.00% | – |
| Q4 2021 | $653,000 | -51.3% | 168,822 | -6.0% | 0.00% | – |
| Q3 2021 | $1,342,000 | +4.6% | 179,642 | -2.5% | 0.00% | – |
| Q2 2021 | $1,283,000 | +2.6% | 184,271 | +16.7% | 0.00% | – |
| Q1 2021 | $1,251,000 | -3.9% | 157,871 | -4.6% | 0.00% | – |
| Q4 2020 | $1,302,000 | +10.4% | 165,459 | -0.5% | 0.00% | – |
| Q3 2020 | $1,179,000 | -38.8% | 166,292 | -20.2% | 0.00% | -100.0% |
| Q2 2020 | $1,928,000 | +366.8% | 208,402 | +135.2% | 0.00% | – |
| Q1 2020 | $413,000 | -39.3% | 88,588 | -0.4% | 0.00% | – |
| Q4 2019 | $680,000 | -35.9% | 88,943 | -35.6% | 0.00% | – |
| Q3 2019 | $1,061,000 | +11.6% | 138,013 | -0.6% | 0.00% | – |
| Q2 2019 | $951,000 | – | 138,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 524,929 | $2,588,000 | 6.20% |
| DAFNA Capital Management LLC | 349,592 | $1,723,000 | 1.07% |
| Nantahala Capital Management | 1,602,903 | $7,902,000 | 0.39% |
| Sio Capital Management, LLC | 129,583 | $639,000 | 0.33% |
| Rock Springs Capital Management LP | 524,089 | $2,584,000 | 0.12% |
| Orbimed Advisors | 1,469,524 | $7,244,000 | 0.07% |
| Baker Brothers Advisors | 1,137,872 | $5,609,000 | 0.04% |
| Lee Financial Co | 22,408 | $110,000 | 0.04% |
| Spark Investment Management LLC | 42,002 | $207,000 | 0.01% |
| JENNISON ASSOCIATES LLC | 1,385,067 | $6,565,000 | 0.01% |